April 2026
The global tumor ablation market size is exhibited at USD 2.18 billion in 2025 and is predicted to be worth around USD 7.47 billion by 2035, with a CAGR of 13.11%.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 2.88 billion in 2025, at a solid CAGR of 6.00%.
June 2026
The global circulating tumor cells market size was evaluated at USD 14.68 billion in 2025 and is predicted to hit around USD 54.76 billion by 2035, growing at a CAGR of 14.07%.
April 2026
The global ultrasonic tissue ablation system market size was evaluated at USD 594.02 million in 2025 and is predicted to hit around USD 2,114.90 million by 2035, growing at a CAGR of 13.54%.
February 2026
The global cryoballoon ablation system market size was evaluated at USD 1.43 billion in 2025 and is predicted to hit around USD 2.49 billion by 2035, growing at a CAGR of 5.70%.
January 2026
The global electrophysiology ablation market size was evaluated at USD 7.17billion in 2025 and is predicted to hit around USD 21.86 billion by 2035, growing at a CAGR of 11.80%.
November 2025
The global ablation devices market size is evaluated at USD 10.84 billion in 2025 and is predicted to hit around USD 26.64 billion by 2035, with a CAGR of 9.41%.
October 2025
The global circulating tumor DNA (ctDNA) market size is estimated to hit around USD 27.67 billion by 2034 increasing from USD 7.96 billion in 2025, with a CAGR of 14.85%.
July 2025
The global ventricular tachycardia (VT) ablation market is poised for growth, driven by the increasing prevalence of cardiovascular diseases linked to aging populations and lifestyle changes.
July 2025
Explore the pan-tumor oncology treatment market, driven by breakthroughs in immunotherapy, targeted treatments, and the rise of tumor-agnostic drug approvals across multiple cancer types.
July 2025
The global tumor necrosis factor inhibitor drugs market size is projected to hit around USD 51.55 billion by 2034 from USD 42.86 billion in 2024 with a CAGR of 1.86%.
June 2025
The global cardiac ablation market size was evaluated at USD 5.11 billion in 2024 and is projected to worth around USD 19.09 billion by 2034, with a CAGR of 14.20%.
June 2025
The global microwave ablation devices market size is estimated to hit around USD 1,466.66 million by 2034 increasing from USD 450.05 million in 2024, with a CAGR of 12.54%.
May 2025
The global endometrial ablation market size was exhibited at USD 1.28 billion in 2024 and is projected to surpass around USD 2.15 billion by 2034, with a notable CAGR of 5.32%.